Literature DB >> 623910

Endotoxin-induced changes in human platelet membranes: morphologic evidence.

D H Ausprunk, J Das.   

Abstract

Interaction between human platelets and bacterial endotoxin was studied in vitro with transmission and scanning electron microscopy. Washed human platelets, whose aggregation was blocked with apyrase, were incubated in a plasma-free medium containing crude endotoxin that had previously been complexed with copper. Thirty minutes of incubation resulted in adherence of endotoxin particles to the platelet surface, breaks in the platelet plasma membrane with apparent attempts at repair, pseudoped formation, and centralization of platelet organelles. Copper appeared to potentiate these phenomena, since neither Cu2+ at low concentrations nor endotoxin alone altered the morphology of the platelet membrane. This platelet-endotoxin interaction may be an intermediary step in the detoxification and clearance of endotoxin from the plasma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 623910

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro.

Authors:  B S Schwartz; M C Monroe
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  Functional and ultrastructural alterations of autologous platelets labeled with 111In-oxine.

Authors:  P Bernard; M Bazan; C Foa; K Mountaz; I Juhan-Vague
Journal:  Eur J Nucl Med       Date:  1983

Review 3.  Interaction of platelets with bacterial endotoxins.

Authors:  N Semeraro; A Lattanzio
Journal:  Agents Actions       Date:  1983-08

4.  Treatment of septic thrombocytopenia with immune globulin.

Authors:  E R Burns; V Lee; A Rubinstein
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

5.  Significance of platelets in an antimetastatic activity of bacterial lipopolysaccharide.

Authors:  M Kimoto; K Ando; S Koike; T Matsumoto; T Jibu; H Moriya; S Kanegasaki
Journal:  Clin Exp Metastasis       Date:  1993-05       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.